Andrew J. Basinski

Andrew J. Basinski

Auto-generated profile, based on publicly available information

Andrew J. Basinski

Department of Mathematics University of Idaho Moscow ID USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2021 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
ABAndrew J. Basinski
Andrew J. Basinski
EFElisabeth Fichet-Calvet
Elisabeth Fichet-Calvet
ASAnna R. Sjodin
Anna R. Sjodin
TVTanner J. Varrelman
Tanner J. Varrelman
CRChristopher H. Remien
Christopher H. Remien
SNScott L. Nuismer
Scott L. Nuismer
Forecasting the risk of pathogen spillover from reservoir populations of wild or domestic animals is essential for the effective deployment of interventions such as wildlife vaccination or culling. Due to the sporadic nature of spillover events and limited availability of data, developing and validating robust, spatially explicit, predictions is challenging. Recent efforts have begun to make progress in this direction by capitalizing on machine learning methodologies. An important weakness of existing approaches, however, is that they generally rely on combining human and reservoir infection data during the training process and thus conflate risk attributable to the prevalence of the pathogen in the reservoir population with the risk attributed to the realized rate of spillover into the human population. Because effective planning of interventions requires that these components of risk be disentangled, we developed a multi-layer machine learning framework that separates these processes. Our approach begins by training models to predict the geographic range of the primary reservoir and the subset of this range in which the pathogen occurs. The spillover risk predicted by the product of these reservoir specific models is then fit to data on realized patterns of historical spillover into the human population. The result is a geographically specific spillover risk forecast that can be easily decomposed and used to guide effective intervention. Applying our method to Lassa virus, a zoonotic pathogen that regularly spills over into the human population across West Africa, results in a model that explains a modest but statistically significant portion of geographic variation in historical patterns of spillover. When combined with a mechanistic mathematical model of infection dynamics, our spillover risk model predicts that 897,700 humans are infected by Lassa virus each year across West Africa, with Nigeria accounting for more than half of these human infections.

1 January 2018 in Vaccine
Verified
Journal Article
Open access
ABAndrew J. Basinski
Andrew J. Basinski
TVTanner J. Varrelman
Tanner J. Varrelman
MSMark W. Smithson
Mark W. Smithson
RMRyan H. May
Ryan H. May
CRChristopher H. Remien
Christopher H. Remien
SNScott L. Nuismer
Scott L. Nuismer
Transmissible vaccines have the potential to revolutionize infectious disease control by reducing the vaccination effort required to protect a population against a disease. Recent efforts to develop transmissible vaccines focus on recombinant transmissible vaccine designs (RTVs) because they pose reduced risk if intra-host evolution causes the vaccine to revert to its vector form. However, the shared antigenicity of the vaccine and vector may confer vaccine-immunity to hosts infected with the vector, thwarting the ability of the vaccine to spread through the population. We build a mathematical model to test whether a RTV can facilitate disease management in instances where reversion is likely to introduce the vector into the population or when the vector organism is already established in the host population, and the vector and vaccine share perfect cross-immunity. Our results show that a RTV can autonomously eradicate a pathogen, or protect a population from pathogen invasion, when cross-immunity between vaccine and vector is absent. If cross-immunity between vaccine and vector exists, however, our results show that a RTV can substantially reduce the vaccination effort necessary to control or eradicate a pathogen only when continuously augmented with direct manual vaccination. These results demonstrate that estimating the extent of cross-immunity between vector and vaccine is a critical step in RTV design, and that herpesvirus vectors showing facile reinfection and weak cross-immunity are promising.

16 November 2019 in Journal of Applied Ecology
Verified
Journal Article
Open access
PDF file
CSCourtney L. Schreiner
Courtney L. Schreiner
SNScott L. Nuismer
Scott L. Nuismer
ABAndrew J. Basinski
Andrew J. Basinski
Wildlife vaccination is an important tool for managing the burden of infectious disease in human populations, domesticated livestock and various iconic wildlife. Although substantial progress has been made in the field of vaccine designs for wildlife, there is a gap in our understanding of how to time wildlife vaccination, relative to host demography, to best protect a population. We use a mathematical model and computer simulations to assess the outcomes of vaccination campaigns that deploy vaccines once per annual population cycle. Optimal timing of vaccination is an important consideration in animals with short to intermediate life spans and a short birthing season. Vaccines that are deployed shortly after the birthing season best protect the host population. The importance of timing is greater in wildlife pathogens that have a high rate of transmission and a short recovery period. Vaccinating at the end of the birthing season best reduces the mean abundance of pathogen‐infected hosts. Delaying vaccination until later in the year can facilitate pathogen elimination. Policy Implications. Tuning wildlife vaccination campaigns to host demography and pathogen traits can substantially increase the effectiveness of a campaign. Our results suggest that, for a fluctuating population, vaccinating at, or shortly after, the end of the birthing season, best protects the population against an invading pathogen. If the pathogen is already endemic, delaying vaccination until after the birthing season is over can help facilitate pathogen elimination. Our results highlight the need to better understand and predict host demography in wildlife populations that are targeted for vaccination.

8 March 2019 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
ABAndrew J. Basinski
Andrew J. Basinski
SNScott L. Nuismer
Scott L. Nuismer
CRChristopher H. Remien
Christopher H. Remien
Zoonotic pathogens such as Ebola and rabies pose a major health risk to humans. One proven approach to minimizing the impact of a pathogen relies on reducing its prevalence within animal reservoir populations using mass vaccination. However, two major challenges remain for vaccination programs that target free-ranging animal populations. First, limited or challenging access to wild hosts, and second, expenses associated with purchasing and distributing the vaccine. Together, these challenges constrain a campaign’s ability to maintain adequate levels of immunity in the host population for an extended period of time. Transmissible vaccines could lessen these constraints, improving our ability to both establish and maintain herd immunity in free-ranging animal populations. Because the extent to which vaccine transmission could augment current wildlife vaccination campaigns is unknown, we develop and parameterize a mathematical model that describes long-term mass vaccination campaigns in the US that target rabies in wildlife. The model is used to investigate the ability of a weakly transmissible vaccine to (1) increase vaccine coverage in campaigns that fail to immunize at levels required for herd immunity, and (2) decrease the expense of campaigns that achieve herd immunity. When parameterized to efforts that target rabies in raccoons using vaccine baits, our model indicates that, with current vaccination efforts, a vaccine that transmits to even one additional host per vaccinated individual could sufficiently augment US efforts to preempt the spread of the rabies virus. Higher levels of transmission are needed, however, when spatial heterogeneities associated with flight-line vaccination are incorporated into the model. In addition to augmenting deficient campaigns, our results show that weak vaccine transmission can reduce the costs of vaccination campaigns that are successful in attaining herd immunity. Zoonotic pathogens pose a significant health risk to humans. Mass vaccination programs have shown promise for controlling zoonoses in reservoir populations and, in turn, lessening the health burden posed to neighboring human populations. Despite some significant successes, major logistical challenges remain for programs that seek to establish and maintain herd immunity in free-ranging animal populations. Specifically, limited host access and costs associated with vaccine distribution may hinder efforts to vaccinate a host population and preempt spillover of a zoonotic pathogen. We use mathematical models, parameterized with data from campaigns in the US that target rabies in wildlife, to illustrate how transmissible vaccines can overcome these challenges. Specifically, we find levels of vaccine transmission necessary to boost vaccination efforts that seek to preempt the spread of rabies, and also predict the cost savings that could be realized with a transmissible vaccine.

1 June 2019 in One Health
Verified
Journal Article
Open access
TVTanner J. Varrelman
Tanner J. Varrelman
ABAndrew J. Basinski
Andrew J. Basinski
CRChristopher Remien
Christopher Remien
SNScott L. Nuismer
Scott L. Nuismer
Transmissible vaccines may provide a promising solution for improving the control of infectious disease, particularly zoonotic pathogens with wildlife reservoirs. Although it is well known that heterogeneity in pathogen transmission impacts the spread of infectious disease, the effects of heterogeneity on vaccine transmission are largely unknown. Here we develop and analyze a mathematical model that quantifies the potential benefits of a transmissible vaccine in a population where transmission is heterogeneous between two subgroups. Our results demonstrate that the effect of heterogeneity on the benefit of vaccine transmission largely depends on the vaccine design and the pattern of vaccine administration across subgroups. Specifically, our results show that in most cases a transmissible vaccine designed to mirror the transmission of the pathogen is optimal. If the vaccination effort can be preferentially biased towards a given subgroup, a vaccine with a pattern of transmission opposite to that of the pathogen can become optimal in some cases. To better understand the consequences of heterogeneity on the effectiveness of a transmissible vaccine in the real world, we parameterized our model using data from Sin Nombre virus in deer mice (Peromyscus maniculatus). The results of this analysis reveal that when a vaccination campaign is limited in vaccine availability, a traditional vaccine must be administered primarily to males for the spread of Sin Nombre virus to be prevented. In contrast, a transmissible vaccine remains effective even when it cannot be preferentially administered to males.

14 September 2022 in Proceedings Of The Royal Society B-Biological Sciences
Verified
Journal Article
Open access
SNScott L. Nuismer
Scott L. Nuismer
ABAndrew J. Basinski
Andrew J. Basinski
CSCourtney Schreiner
Courtney Schreiner
AWAlexander Whitlock
Alexander Whitlock
CRChristopher Remien
Christopher Remien
The ecology and life history of wild animals influences their potential to harbour infectious disease. This observation has motivated studies identifying empirical relationships between traits of wild animals and historical patterns of spillover and emergence into humans. Although these studies have identified compelling broad-scale patterns, they are generally agnostic with respect to underlying mechanisms. Here, we develop mathematical models that couple reservoir population ecology with viral epidemiology and evolution to clarify existing verbal arguments and pinpoint the conditions that favour spillover and emergence. Our results support the idea that average lifespan influences the likelihood of an animal serving as a reservoir for human infectious disease. At the same time, however, our results show that the magnitude of this effect is sensitive to the rate of viral mutation. Our results also demonstrate that viral pathogens causing persistent infections or a transient immune response within the reservoir are more likely to fuel emergence. Genetically explicit stochastic simulations enrich these mathematical results by identifying relationships between the genetic basis of transmission and the risk of spillover and emergence. Together, our results clarify the scope of applicability for existing hypotheses and refine our understanding of emergence risk.